Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

PET-CT in Recurrent Ovarian Cancer: Impact on Treatment Planning

MIRIAM S. LENHARD, ALEXANDER BURGES, THORSTEN R.C. JOHNSON, PETRA STIEBER, CAROLIN KÜMPER, NINA DITSCH, RAINER LINKE and KLAUS FRIESE
Anticancer Research July 2008, 28 (4C) 2303-2308;
MIRIAM S. LENHARD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Miriam.Lenhard@med.uni-muenchen.de
ALEXANDER BURGES
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
THORSTEN R.C. JOHNSON
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PETRA STIEBER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CAROLIN KÜMPER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NINA DITSCH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RAINER LINKE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KLAUS FRIESE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Positron emission tomography-computed tomography (PET-CT) is currently not established in the management of recurrent ovarian cancer. Here, its value in diagnosis and therapy planning was evaluated. Patients and Methods: Seventy patients received PET-CT for suspicion of recurrent ovarian cancer. PET-CT and surgery were reviewed to analyze the accuracy in the diagnosis of recurrence and prediction of full resectability. Results: PET-CT showed disease relapse in 63 of 70 patients, with full sensitivity and specificity. Thirty cases were operated on. PET-CT indicated full resectability in 24, but in fact only incomplete resection was possible in three cases. Thus sensitivity and specificity for the identification of full resectability were 100% and 66%, respectively. Seven negative results in PET-CT were confirmed by a relapse-free follow-up of 1 year. Conclusion: PET-CT offers reliable detection of recurrent ovarian cancer. Although diagnostic accuracy in the prediction of full resectability is limited, surgical planning is improved by identifying sites of intraperitoneal involvement.

  • Ovarian cancer
  • positron emission tomography
  • computed tomography
  • tumor marker

Footnotes

  • ↵* Both authors contributed equally to this article.

  • Received February 20, 2008.
  • Revision received April 23, 2008.
  • Accepted May 2, 2008.
  • Copyright© 2008 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research: 28 (4C)
Anticancer Research
Vol. 28, Issue 4C
July-August 2008
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
PET-CT in Recurrent Ovarian Cancer: Impact on Treatment Planning
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
17 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
PET-CT in Recurrent Ovarian Cancer: Impact on Treatment Planning
MIRIAM S. LENHARD, ALEXANDER BURGES, THORSTEN R.C. JOHNSON, PETRA STIEBER, CAROLIN KÜMPER, NINA DITSCH, RAINER LINKE, KLAUS FRIESE
Anticancer Research Jul 2008, 28 (4C) 2303-2308;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
PET-CT in Recurrent Ovarian Cancer: Impact on Treatment Planning
MIRIAM S. LENHARD, ALEXANDER BURGES, THORSTEN R.C. JOHNSON, PETRA STIEBER, CAROLIN KÜMPER, NINA DITSCH, RAINER LINKE, KLAUS FRIESE
Anticancer Research Jul 2008, 28 (4C) 2303-2308;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Radiomics for Growth Prediction of Vestibular Schwannomas in Neurofibromatosis Type 2
  • Chemotherapy-induced Moderate to Severe Peripheral Neuropathy in Patients Receiving Adjuvant Radiotherapy for Breast Cancer
  • Efficacy and Prognostic Factors of Surgical Resection for Pulmonary Metastases From Ovarian Cancer
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2025 Anticancer Research

Powered by HighWire